Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7588)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2013 (publication date) through Dec 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dias CC, Rodrigues PP, Costa-Pereira AD, Magro F. Clinical prognostic factors for disabling Crohn's disease: A systematic review and meta-analysis. World J Gastroenterol 2013; 19(24): 3866-3871 [PMID: 23840127 DOI: 10.3748/wjg.v19.i24.3866] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i24/3866.htm |
| Number | Citing Articles |
| 1 |
Bruno Augusto Alves Martins, Oswaldo de Moraes Filho, Ana Carolina Benvindo Lopes, Ricardo Jacarandá de Faria, Clíslian Silva, Gabriela de Oliveira Lemos, Dannilo Brito Silveira, João Batista de Sousa. Nutritional status in perianal Crohn’s disease: are we underestimating the impact?. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1271825
|
| 2 |
Paula Ministro, Cláudia Camila Dias, Francisco Portela, Samuel Fernandes, Sónia Bernardo, Francisco Pires, Paula Lago, Isadora Rosa, Eunice Trindade, Catarina Alves, Luís Correia, Fernando Magro. Age at Diagnosis Is Determinant for the Outcome of Inflammatory Bowel Disease: Is It a Myth?. Clinical and Translational Gastroenterology 2021; 12(2): e00309 doi: 10.14309/ctg.0000000000000309
|
| 3 |
Claudia Camila Dias, Fernando Magro, Pedro Pereira Rodrigues. Disabling and Reoperation in Patients with Crohn's Disease Subject to Early Surgery or Immunosuppression: A Bayesian Network Prognostic Model. 2016 IEEE 29th International Symposium on Computer-Based Medical Systems (CBMS) 2016; : 265 doi: 10.1109/CBMS.2016.65
|
| 4 |
J.K. Yamamoto-Furusho, F. Bosques-Padilla, J. de-Paula, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.L. Rocha, F. Steinwurz, G. Veitia, C. Zaltman. Diagnóstico y tratamiento de la enfermedad inflamatoria intestinal: Primer Consenso Latinoamericano de la Pan American Crohn's and Colitis Organisation. Revista de Gastroenterología de México 2017; 82(1): 46 doi: 10.1016/j.rgmx.2016.07.003
|
| 5 |
Fernando Magro, Cláudia C. Dias, Rosa Coelho, Paula M. Santos, Samuel Fernandes, Cidalina Caetano, Ângela Rodrigues, Francisco Portela, Ana Oliveira, Paula Ministro, Eugénia Cancela, Ana I. Vieira, Rita Barosa, José Cotter, Pedro Carvalho, Isabelle Cremers, Daniel Trabulo, Paulo Caldeira, Artur Antunes, Isadora Rosa, Joana Moleiro, Paula Peixe, Rita Herculano, Raquel Gonçalves, Bruno Gonçalves, Helena Tavares Sousa, Luís Contente, Henrique Morna, Susana Lopes. Impact of Early Surgery and Immunosuppression on Crohnʼs Disease Disabling Outcomes. Inflammatory Bowel Diseases 2017; 23(2): 289 doi: 10.1097/MIB.0000000000001007
|
| 6 |
Yoo Min Han, Jaemoon Koh, Ji Won Kim, Changhyun Lee, Seong-Joon Koh, ByeongGwan Kim, Kook Lae Lee, Jong Pil Im, Joo Sung Kim, Gernot Sellge. NF-kappa B activation correlates with disease phenotype in Crohn’s disease. PLOS ONE 2017; 12(7): e0182071 doi: 10.1371/journal.pone.0182071
|
| 7 |
Min Seob Kwak, Duk Hwan Kim, Soo Jung Park, Tae Il Kim, Sung Pil Hong, Won Ho Kim, Jae Hee Cheon. Efficacy of early immunomodulator therapy on the outcomes of Crohn’s disease. BMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-85
|
| 8 |
Claudia Camila Dias, Fernando Magro, Pedro Pereira Rodrigues. Preliminary Study for a Bayesian Network Prognostic Model for Crohn's Disease. 2015 IEEE 28th International Symposium on Computer-Based Medical Systems 2015; : 141 doi: 10.1109/CBMS.2015.40
|
| 9 |
Christopher R. Lindholm, Corey A. Siegel. Are We Ready to Include Prognostic Factors in Inflammatory Bowel Disease Trials?. Current Pharmaceutical Design 2019; 25(1): 64 doi: 10.2174/1381612825666190312113935
|
| 10 |
Cláudia Camila Dias, Pedro Pereira Rodrigues, Rosa Coelho, Paula Moura Santos, Samuel Fernandes, Paula Lago, Cidalina Caetano, Ângela Rodrigues, Francisco Portela, Ana Oliveira, Paula Ministro, Eugénia Cancela, Ana Isabel Vieira, Rita Barosa, José Cotter, Pedro Carvalho, Isabelle Cremers, Daniel Trabulo, Paulo Caldeira, Artur Antunes, Isadora Rosa, Joana Moleiro, Paula Peixe, Rita Herculano, Raquel Gonçalves, Bruno Gonçalves, Helena Tavares Sousa, Luís Contente, Henrique Morna, Susana Lopes, Fernando Magro. Development and Validation of Risk Matrices for Crohn’s Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions. Journal of Crohn's and Colitis 2016; : jjw171 doi: 10.1093/ecco-jcc/jjw171
|
| 11 |
J.K. Yamamoto-Furusho, F. Bosques-Padilla, J. de-Paula, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.L. Rocha, F. Steinwurz, G. Veitia, C. Zaltman. Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation. Revista de Gastroenterología de México (English Edition) 2017; 82(1): 46 doi: 10.1016/j.rgmxen.2016.07.003
|
| 12 |
Clémentine Lauriot dit Prevost, Mustapha Azahaf, Maria Nachury, Julien Branche, Romain Gerard, Pauline Wils, Thomas Lambin, Pierre Desreumaux, Olivier Ernst, Benjamin Pariente. Bowel damage and disability in Crohn's disease: a prospective study in a tertiary referral centre of the Lémann Index and Inflammatory Bowel Disease Disability Index . Alimentary Pharmacology & Therapeutics 2020; 51(9): 889 doi: 10.1111/apt.15681
|
| 13 |
Subrata Ghosh, Marietta Iacucci. Role of Immunosuppressives in Special Situations: Perianal Disease and Postoperative Period. Digestive Diseases 2014; 32(Suppl. 1): 92 doi: 10.1159/000367835
|
| 14 |
Reema Harrison, Benjamin Jones, Peter Gardner, Rebecca Lawton. Quality assessment with diverse studies (QuADS): an appraisal tool for methodological and reporting quality in systematic reviews of mixed- or multi-method studies. BMC Health Services Research 2021; 21(1) doi: 10.1186/s12913-021-06122-y
|
| 15 |
Augusto Lauro, Francesco D’Amico, Gabriel Gondolesi. The current therapeutic options for Crohn’s disease: from medical therapy to intestinal transplantation. Expert Review of Gastroenterology & Hepatology 2017; 11(12): 1105 doi: 10.1080/17474124.2017.1367665
|
| 16 |
Florian Bär, Thomas Krause, Andreas Stallmach, Niels Teich, Christian Maaser, Jochen Maul, Ulf Helwig, Klaus Fellermann, Jürgen Büning. Cyclophosphamide Pulse Therapy in Severe Refractory Crohn's Disease: A Retrospective Multicenter Case Series. Inflammatory Intestinal Diseases 2017; 2(3): 139 doi: 10.1159/000481820
|
| 17 |
Hunter Bratton, Mohammad Alomari, Laith Al Momani, Pravallika Chadalavada, Fahrettin Covut, May Olayan, Mark Young. Etiology of and predictive factors for chronic intestinal failure requiring long term parenteral support in the last two decades: A retrospective study. Clinical Nutrition ESPEN 2020; 37: 168 doi: 10.1016/j.clnesp.2020.02.019
|
| 18 |
Umar Darr, Nabeel Khan. Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature. Current Treatment Options in Gastroenterology 2017; 15(1): 116 doi: 10.1007/s11938-017-0130-6
|
| 19 |
Katharina Büsch, Amnon Sonnenberg, Nick Bansback. Impact of Inflammatory Bowel Disease on Disability. Current Gastroenterology Reports 2014; 16(10) doi: 10.1007/s11894-014-0414-0
|
| 20 |
Yu Kyung Jun, Eunjeong Ji, Hye Ran Yang, Yonghoon Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Hyuk Yoon. Differences in the risk of clinical failure between thiopurine and methotrexate in bio-naïve patients with Crohn’s disease: a Korean nationwide population-based study. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241248321
|
| 21 |
J.K. Yamamoto-Furusho, J.G. López-Gómez, F.J. Bosques-Padilla, M.A. Martínez-Vázquez, J.L. De-León-Rendón. Primer consenso mexicano de la enfermedad de Crohn. Revista de Gastroenterología de México 2024; 89(2): 280 doi: 10.1016/j.rgmx.2024.03.003
|
| 22 |
Kata Szántó, Tibor Nyári, Anita Bálint, Renáta Bor, Ágnes Milassin, Mariann Rutka, Anna Fábián, Zoltán Szepes, Ferenc Nagy, Tamás Molnár, Klaudia Farkas, John Green. Biological therapy and surgery rates in inflammatory bowel diseases – Data analysis of almost 1000 patients from a Hungarian tertiary IBD center. PLOS ONE 2018; 13(7): e0200824 doi: 10.1371/journal.pone.0200824
|
| 23 |
Wolfgang Kruis, Bernd Bokemeyer, Petra Jessen, Mark Hoesl, Michael Mroß, Julia Morgenstern, Birgitta Reimers, Nike Müller-Grage, Ludger Leifeld. Prospective Evaluation of the Prediction Score for a Mild Course of Crohn’s Disease (PreMiCC) in Newly Diagnosed Patients With Crohn’s Disease: The PROGNOS Study. Inflammatory Bowel Diseases 2024; doi: 10.1093/ibd/izae086
|
| 24 |
Jan Marsal, Manuel Barreiro-de Acosta, Irina Blumenstein, Maria Cappello, Thomas Bazin, Shaji Sebastian. Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.897936
|
| 25 |
Yoon Suk Jung, Minkyung Han, Won Ho Kim, Sohee Park, Jae Hee Cheon. Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011–2014: A Nationwide Population-Based Study. Digestive Diseases and Sciences 2017; 62(8): 2102 doi: 10.1007/s10620-017-4640-9
|
| 26 |
Cláudia Camila Dias, Francisco Portela, Samuel Fernandes, Paula Ministro, Paula Lago, Isadora Rosa, Luis Correia, Fernando Magro. The timing of early therapeutic strategies has a significant impact on Crohn’s disease prognosis. Digestive and Liver Disease 2018; 50(5): 462 doi: 10.1016/j.dld.2018.01.135
|
| 27 |
Loredana Goran, Monica State, Ana Maria Negreanu, Lucian Negreanu. Pursuing therapeutic success in Crohn’s disease: A matter of definition, tools and longterm outcomes. European Journal of Inflammation 2020; 18: 205873922096289 doi: 10.1177/2058739220962896
|
| 28 |
Guillermo Bastida Paz, Olga Merino Ochoa, Mariam Aguas Peris, Manuel Barreiro-de Acosta, Yamile Zabana, Daniel Ginard Vicens, Daniel Ceballos Santos, Fernando Muñoz Núñez, David Monfort i Miquel, Ignacio Catalán-Serra, Valle García Sánchez, Carmen Loras Alastruey, Alfredo Lucendo Villarín, Jose Maria Huguet, Cristóbal de la Coba Ortiz, Xavier Aldeguer Manté, Antonio Palau Canós, Eugeni Domènech Morral, Pilar Nos. The Risk of Developing Disabling Crohn’s Disease: Validation of a Clinical Prediction Rule to Improve Treatment Decision Making. Digestive Diseases 2023; 41(6): 879 doi: 10.1159/000531789
|
| 29 |
Carolina Palmela, Joana Torres, Marilia Cravo. New Trends in Inflammatory Bowel Disease. GE Portuguese Journal of Gastroenterology 2015; 22(3): 103 doi: 10.1016/j.jpge.2015.03.009
|
| 30 |
Dana Rachel Berg, Jean-Frederic Colombel, Ryan Ungaro. The Role of Early Biologic Therapy in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019; 25(12): 1896 doi: 10.1093/ibd/izz059
|
| 31 |
E. G. Ganich, O. B. Shchukina. Features of Crohn's Disease Depending on the Age of Disease Onset. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2023; 33(5): 65 doi: 10.22416/1382-4376-2023-33-5-65-77
|
| 32 |
Andres Yarur, Gerassimos J. Mantzaris, Song Wang, Shashi Adsul, Pravin Kamble, Erin Cook, Gautam Sajeev, Annie Guerin, Brian Bressler. Stratified Patient Profiling for Vedolizumab Effectiveness in Crohn’s Disease: Identifying Optimal Subgroups for Enhanced Treatment Response in the EVOLVE Study. Advances in Therapy 2024; 41(6): 2324 doi: 10.1007/s12325-024-02825-w
|
| 33 |
J.K. Yamamoto-Furusho, J.G. López-Gómez, F.J. Bosques-Padilla, M.A. Martínez-Vázquez, J.L. De-León-Rendón. First Mexican Consensus on Crohn’s disease. Revista de Gastroenterología de México (English Edition) 2024; 89(2): 280 doi: 10.1016/j.rgmxen.2024.03.001
|
| 34 |
Shankar Kumar, Andrew Plumb, Sue Mallett, Gauraang Bhatnagar, Stuart Bloom, Caroline S Clarke, John Hamlin, Ailsa L Hart, Ilan Jacobs, Simon Travis, Roser Vega, Steve Halligan, Stuart Andrew Taylor. METRIC-EF: magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn’s disease—protocol for a multicentre, non-randomised, single-arm, prospective study. BMJ Open 2022; 12(10): e067265 doi: 10.1136/bmjopen-2022-067265
|
| 35 |
Maria Di Girolamo, Alessandro Sartini, Rosina Critelli, Angela Bertani, Alberto Merighi, Erica Villa. Efficacy of a Novel Granulocyte Monocyte Apheresis Adsorber Device in the Treatment of Inflammatory Bowel Diseases: A Pilot Study. Therapeutic Apheresis and Dialysis 2016; 20(6): 668 doi: 10.1111/1744-9987.12453
|
| 36 |
Rafael López-Cortés, Raquel Herrero-Hahn, Rosanna De la Rosa-Eduardo, Rafael Montoya-Juárez, María Paz García-Caro, Blanca Marín-Fernández, César Hueso-Montoro. Cultural Adaptation and Validation of the Inflammatory Bowel Disease Disability Index in a Spanish Population and Its Association with Sociodemographic and Clinical Factors. International Journal of Environmental Research and Public Health 2019; 16(4): 635 doi: 10.3390/ijerph16040635
|
| 37 |
Berkeley N. Limketkai, Alyssa M. Parian, Neha D. Shah, Jean-Frédéric Colombel. Short Bowel Syndrome and Intestinal Failure in Crohnʼs Disease. Inflammatory Bowel Diseases 2016; 22(5): 1209 doi: 10.1097/MIB.0000000000000698
|
| 38 |
Cláudia Camila Dias, Pedro Pereira Rodrigues, Samuel Fernandes, Francisco Portela, Paula Ministro, Diana Martins, Paula Sousa, Paula Lago, Isadora Rosa, Luis Correia, Paula Moura Santos, Fernando Magro, Francesco Pappalardo. The risk of disabling, surgery and reoperation in Crohn’s disease – A decision tree-based approach to prognosis. PLOS ONE 2017; 12(2): e0172165 doi: 10.1371/journal.pone.0172165
|